Ligand Pharmaceuticals Incorporated
—Price / book
Market cap
—
Tangible equity
$690.23M
Price / tangible book
—
Price / book
—
Return on equity
12.2%
Return on assets
8.0%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $25.06B · View financials
Decision snapshot: LGND stock price vs PFG: inconclusive — current versus $135.47 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFG's multiple
Implied fair value · at LGND's multiple
Needs LGND P/E.
Snapshot Sep 8, 10:13 AM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability edge
Asset efficiency edge
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: LGND FY 2025 (ended Dec 31, 2025) · PFG FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
$690.23M
Price / tangible book
—
Price / book
—
Return on equity
12.2%
Return on assets
8.0%
Efficiency ratio
—
Price / tangible book
Market cap
$25.06B
Tangible equity
$9.02B
Price / tangible book
2.78x
Price / book
2.11x
Return on equity
10.0%
Return on assets
0.3%
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LIGAND PHARMACEUTICALS INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
PRINCIPAL FINANCIAL GROUP, INC · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.37x
0.33x
Net debt / EBITDA
Leverage against operating earnings
-2.24x
-0.30x
Cash and equivalents
Liquid reserves on the balance sheet
$733.52M
$4.43B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Royalty Pharma plc
LGND vs RPRX
Sarepta Therapeutics, Inc.
LGND vs SRPT
INCYTE CORP
LGND vs INCY
EXELIXIS, INC.
LGND vs EXEL
METLIFE INC
LGND vs MET
PRUDENTIAL FINANCIAL INC
LGND vs PRU
LINCOLN NATIONAL CORP
LGND vs LNC
HARTFORD FINANCIAL SERVICES GROUP, INC.
LGND vs HIG
AMERIPRISE FINANCIAL INC
LGND vs AMP
$374.08M
$3.95B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.